Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experienceCharikleia Kelaidi, Sylvie Chevret, Stéphane De Botton, et al.
Haematologica|September 24, 2009
Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaSébastien Maury, Françoise Huguet, Thibaut Leguay, et al.
Blood Advances|October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AMLJuliette Lambert, Jerome Lambert, Xavier Thomas, et al.
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
Cell Death & Disease|September 29, 2018
A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcomeThibault Voeltzel, Mario Flores-Violante, Florence Zylbersztejn, et al.
Blood|March 25, 2004
A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)Christiane Charrin, Xavier Thomas, Martine Ffrench, et al.
Blood|June 22, 2011
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 studyXavier Thomas, Mohamed Elhamri, Emmanuel Raffoux, et al.
Cancers|January 8, 2020
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex KaryotypeLaurène Fenwarth, Nicolas Duployez, Xavier Thomas, et al.
Annals of Hematology|January 25, 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective studyLudovic Gabellier, Pierre Peterlin, Sylvain Thepot, et al.
Blood|December 28, 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaElise Fournier, Nicolas Duployez, Benoît Ducourneau, et al.
Pageof 27